{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:42:29Z","timestamp":1789879349806,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.diagmicrobio.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T16:46:44Z","timestamp":1461343604000},"page":"318-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples"],"prefix":"10.1016","volume":"85","author":[{"given":"Ardashel","family":"Latsuzbaia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1423-2294","authenticated-orcid":false,"given":"Jessica","family":"Tapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Weyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-9835","authenticated-orcid":false,"given":"Jo\u00ebl","family":"Mossong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2016.04.011_bb0005","first-page":"S14","article-title":"VALGENT: A protocol for clinical validation of human papillomavirus assays","volume":"76","author":"Arbyn","year":"2015","journal-title":"J Clin Virol"},{"issue":"Suppl. 5","key":"10.1016\/j.diagmicrobio.2016.04.011_bb0010","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000314010","article-title":"Introduction of human papillomavirus vaccination in Belgium, Luxembourg and the Netherlands","volume":"70","author":"Arbyn","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4424","article-title":"Are 20 human papillomavirus types causing cervical cancer?","volume":"234","author":"Arbyn","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0035","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiq139","article-title":"Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease","volume":"203","author":"Chaturvedi","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0040","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ijc.29019","article-title":"Judging the carcinogenicity of rare human papillomavirus types","volume":"136","author":"Combes","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/mp.52.5.275","article-title":"The integration of HPV-18 DNA in cervical carcinoma","volume":"52","author":"Corden","year":"1999","journal-title":"Mol Pathol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0050","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2014.03.552","article-title":"Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31\u201365","volume":"133","author":"Dickson","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0060","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1017\/S0950268814001538","article-title":"Recent trends in type-specific HPV infection rates in the United States","volume":"143","author":"Dickson","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0065","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/JCM.02453-13","article-title":"Global Improvement in Genotyping of Human Papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study","volume":"52","author":"Eklund","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0070","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JCM.02749-13","article-title":"Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping","volume":"52","author":"Estrade","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0075","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0080","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0085","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/path.4405","article-title":"Pathogenic role of the eight probably\/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer","volume":"234","author":"Halec","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcv.2016.01.009","article-title":"Clinical validation of Anyplex II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening","volume":"76","author":"Hesselink","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0100","series-title":"Biological agents. Volume 100 B. A review of human carcinogens (Vol. 100)","author":"IARC","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0105","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.cmi.2015.05.011","article-title":"Molecular methods for identification and characterization of novel papillomaviruses","volume":"21","author":"Kocjan","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcv.2014.01.015","article-title":"Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection","volume":"59","author":"Kwon","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jmoldx.2014.12.004","article-title":"Evaluation of HPV Genotyping Assays for Archival Clinical Samples","volume":"17","author":"Lillsunde Larsson","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jviromet.2015.02.018","article-title":"Performance evaluation of AnyplexII HPV28 detection kit in a routine diagnostic setting: comparison with the HPV Sign(R) Genotyping Test","volume":"217","author":"Marcuccilli","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-9-164","article-title":"Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits","volume":"9","author":"Meiring","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Munoz","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jmv.21382","article-title":"Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes","volume":"81","author":"Sandri","year":"2009","journal-title":"J Med Virol"},{"issue":"Suppl. 5","key":"10.1016\/j.diagmicrobio.2016.04.011_bb0140","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2010.03.007","article-title":"HPV genotype distribution according to severity of cervical neoplasia","volume":"118","author":"Sjoeborg","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diagmicrobio.2016.04.011_bb0150","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/aje\/kwu267","article-title":"Concurrence of multiple human papillomavirus infections in a large US population-based cohort","volume":"180","author":"Yang","year":"2014","journal-title":"Am J Epidemiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931630089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931630089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T22:46:52Z","timestamp":1718491612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288931630089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S073288931630089X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.04.011","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}